Decline in decreased cephalosporin susceptibility and increase in azithromycin resistance in neisseria gonorrhoeae, Canada

Emerging Infectious Diseases

Volumn 22, Issue 1, 2016, Pages 65-67

  Martin, Irene ^a   Sawatzky, P ^a   Liu, G ^a   Allen, V ^b   Lefebvre, B ^c   Hoang, L ^d   Drews, S ^e   Horsman, G ^f   Wylie, J ^g   Haldane, D ^h   Garceau, R ⁱ   Ratnam, S ^j   Wong, T ^a   Archibald, C ^a   Mulvey, M R ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^f Saskatchewan Disease Control Laboratory   (Canada)

^g CADHAM PROVINCIAL LABORATORY   (Canada)

^h QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

ⁱ Dumont Hospital   (Canada)

^j Newfoundland and Labrador Public Health Laboratory   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

AGAR DILUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; CHILD; DISEASE SURVEILLANCE; FEMALE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CANADA; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE;

EID: 84950239533     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2201.151247     Document Type: Article

References (14)

1. Public Health Agency of Canada. Notifiable diseases on-line. 2015 [cited 2015 Sep 18]. http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ ndis/charts.php?c=pl
2. World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae [cited 2012 Jun 12]. http://www.who.int/reproductivehealth/ publications/rtis/9789241503501/en
3. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555–7. http://dx.doi.org/10.1517/14656560902731993
4. Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections, gonococcal infections: revised July 2013 [cited 2014 Jul 22]. http://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement. CLSI document, approved standard M100–S24. Wayne (PA): The Institute; 2014.
6. Martin I, Jayaraman G, Wong T, Liu G, Gilmour M. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000–2009. Sex Transm Dis. 2011;38:892–8. http://dx.doi.org/10.1097/OLQ.0b013e31822c664f
7. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2007 supplement, Gonococcal Isolate Surveillance Project (GISP) annual report 2007 [cited 2010 Nov 30]. http://www.cdc.gov/std/gisp2007/gispsurvsupp2007short.pdf
8. Bignell C, FitzGerald M. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS. 2011;22:541-7. http://dx.doi.org/10.1258/ijsa.2011.011267
9. Public Health England. GRASP 2013 report: the Gonococcal Resistance to Antimicrobial Surveillance Programme (England and Wales). 2014 [cited 2015 Jun 25]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/368477/GRASP_Report_2013.pdf
10. Centers for Disease Control and Prevention. Update to CDC’s sexually transmitted diseases treatment guidelines, 2010; oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012; 61:590–4.
11. Kirkcaldy RD, Kidd S, Weinstock HS, Papp JR, Bolan GA. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the gonococcal isolate surveillance project (GISP), January 2006–June 2012. Sex Transm Infect. 2013;89(Suppl 4):iv5–vi10. http://dx.doi.org/10.1136/sextrans-2013-051162
12. Centers for Disease Control and Prevention. 2013 Sexually transmitted diseases surveillance. Gonorrhea. 2014 [cited 2015 Oct 26]. http://www.cdc.gov/std/stats13/gonorrhea.htm
13. Lahra MM. Australian Gonococcal Surveillance Programme annual report, 2013. Commun Dis Intell Q Rep. 2015;39:E137–45.
14. Public Health Agency of Canada, National Microbiology Laboratory. National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae annual summary 2013 [cited 2015 Jun 25]. http://healthycanadians.gc.ca/publications/drugs-products-medicaments-produits/2013-neisseria/index-eng.php